EC approves first-line ovarian cancer treatment
European Pharmaceutical Review
NOVEMBER 22, 2023
Thomas’ NHS Foundation Trust and King’s College London, London, UK, and European Network of Gynaecological Oncological Trial (ENGOT) lead of the ATHENA trial for rucaparib.
Let's personalize your content